Tiffany Hu, MD
Cardiovascular Disease · Boston, MANPI 1588028773
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.4%), food and beverage and grants — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 58.5% of the total. Reporting peaked in 2023 at $12,594 and has fallen 59.3% since, to $5,123 in 2025.
Across 262 payments — averaging $140.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Medical Device Business Services, Inc.$4K
- Boston Scientific$4K
- Abbott$4K
- Biotronik Inc.$2K
- Philips North America LLC$614
- plus $780 from 4 others
What the payments were for
- Grants$6,66718%
- Travel & lodging$16,65445%
- Food & beverage$12,83535%
- Education$5602%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 141 | $21,480 |
| Medical Device Business Services, Inc. | 20 | $4,342 |
| Boston Scientific | 37 | $3,823 |
| Abbott | 35 | $3,520 |
| Biotronik Inc. | 11 | $2,155 |
| Philips North America LLC | 5 | $614 |
| Biosense Webster, Inc. | 10 | $428 |
| Atricure, Inc. | 1 | $200 |
| Abiomed | 1 | $101 |
| Getinge USA Sales, LLC | 1 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$4,419
- Micra$2,219
- ENSITE PRECISION$1,836
- EVERA MRI XT DR SURESCAN$1,560
- WATCHMAN Access System$783
- (9520) IGT Devices Undivided$385
- AURORA EV-ICD MRI SURESCAN$268
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$255
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$200
- AVVIGO Guidance System$160
- COBALT DR MRI SURESCAN$159
- OPTICROSS$134
- RESONATE EL ICD VR$125
- Impella$101
- ENSITE$101
How this compares
$36,715 in reported general payments places this provider in the 85th percentile of 750 cardiovascular disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $13,527 |
| Omeprazole | 12 | $99 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Boston
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
- Ignacio Inglessis-AzuajeBoston$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.